Hints and tips:
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Speculation is rife that one player, IVC Evidensia, may be set to join the pair through a stock exchange admission....
...In truth, the practice is rife. Celgene, a US biotech group, is among the drugmakers that recently promised moderation....
...Doubtful drugmakers Erik Nordkamp, the managing director of Pfizer UK, warns that the UK pharmaceuticals industry, which employs more than 140,000 people, urgently needs reform....
...Ford, Pfizer and Nestlé were among the brands that took part in the investigation, which provides the clearest sign yet that fraud is rife in the fast-growing online advertising market....
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...On Sunday, reports surfaced that Pfizer, the US drugs maker, had held discussions with AstraZeneca, the UK pharmaceutical group, over a possible $100bn takeover....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...But revealing how you would model risk on a single benchmark portfolio seems rife with its own shortcomings....
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...But in spite of their eager anticipation, the proposed sale of TeliaSonera is rife with complications that present any potential bidder sitting on the sidelines with a formidable range of political obstacles...
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
...Political uncertainty is rife and many visitors are still avoiding travel in the area....
International Edition